Evidence map›Paper›PMID 15348367›Full record

ArticleJournal of materials science. Materials in medicine

Does a pro-angiogenic state exist in the bone-implant interface of aseptically loosened joint prosthesis?

G M Jell, N Al-Saffar

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2009
    Article
  3. Gene activation by bioactive glasses.Journal of materials science. Materials in medicine · 2006
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

G M JellDepartment of Histopathology and the IRC in Biomedical Materials, Royal Free Campus, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK.
N Al-Saffar

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neovascularization is indispensable to both bone remodeling and the development of chronic inflammation. A pro-angiogenic state in the periprosthetic tissue may augment the inflammatory response to wear debris. To investigate if a pro-angiogenic state exists in the bone-implant interface of aseptically loosened joint prosthesis, the expression of vascular endothelial growth factor (VEGF) and its receptor Flk-1/KDR were studied by immunohistochemistry. The VEGF-Flk/KDR pathway has been implicated as a key signaling requirement for pathological angiogenesis. The level of vascularization in periprosthetic tissue was semi-quantitatively compared to osteoarthritic (OA) and rheumatoid arthritic (RA) synovium. The level of vascularization in areas of periprosthetic tissue with heavy or low/moderate wear debris were also compared semi-quantitatively by image analysis. High levels of VEGF expression (16/16 cases) particularly in the implant synovial-like lining layer together with Flk-1/KDR expression by endothelial cells (13/16), suggests that neovascularization is occurring. Morphometric comparison of periprosthetic tissue with RA and OA synovium revealed no significant difference in microvessel density, but did reveal significantly increased microvessel area in RA synovium (P > 0.05). Areas of high wear debris infiltrate also contained a significantly smaller microvessel area (P > 0.01). Suggesting that wear debris may cause behavioral modification of microvessels. Modifying angiogenesis in the periprosthetic tissue could be a potential therapeutic target in reducing inflammation.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.